Regulation 30 Appeals to an appointed personE1

England, Wales and Scotland

(1)

A person aggrieved by a provisional decision of the Secretary of State under regulation 29 F1or a body aggrieved by a decision to suspend or revoke its recognition under paragraph 14(1) of Schedule 3 may appeal against the decision to a person appointed for the purpose by the Secretary of State in accordance with this regulation.

(2)

So may an applicant for—

(a)

a manufacturing authorisation;

F2(aa)

a variation to a manufacturing authorisation;

(b)

appointment as a Qualified Person for the purposes of a manufacturing authorisation;

(c)

authorisation for a person or premises to manufacture autogenous vaccines;

(d)

an authorisation of a blood bank;

(e)

authorisation of a person and premises to manufacture an unauthorised veterinary medicinal product for administration under the cascade;

(f)

authorisation of F3a stem cell centre;

(g)

a wholesale dealer’s authorisation;

F4(ga)

registration in relation to active substances

(h)

the F5authorisation of premises for the supply of POM-VPS or NFA-VPS veterinary medicinal products by a suitably qualified person,

if such an application is refused.

(3)

A holder of any of the above authorisations F6or appointments may appeal against a suspension F7, revocation or compulsory variation in the same way.

(4)

The appointed person must consider the appeal (but may not consider any new data not available to the Secretary of State at the time of the original decision) and any representations made by the Secretary of State and report in writing, with a recommended course of action, to the Secretary of State.

(5)

The Secretary of State must then reach a final decision and notify the appellant, together with the reasons for it.

Annotations

Textual amendments

F1: Words in reg. 30(1) inserted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 17(a)
F2: Reg. 30(2)(aa) inserted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 17(b)(i)
F3: Words in reg. 30(2)(f) substituted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 17(b)(ii)
F4: Reg. 30(2)(ga) inserted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 17(b)(iii)
F5: Word in reg. 30(2)(h) substituted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 17(b)(iv)
F6: Words in reg. 30(3) substituted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 17(c)(i)
F7: Word in reg. 30(3) inserted (E.W.S.) (17.5.2024) by The Veterinary Medicines (Amendment etc.) Regulations 2024 (S.I. 2024/567), regs. 1(1), 17(c)(ii)

Extent

E1: This version of this provision extends to England and Wales and Scotland only; a separate version has been created for Northern Ireland only